KBPH — Kyto Technology and Life Science Cashflow Statement
0.000.00%
FinancialsHighly SpeculativeMicro Cap
Annual cashflow statement for Kyto Technology and Life Science, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2017 March 31st | 2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.094 | -0.091 | -0.23 | -0.773 | 0.427 |
| Non-Cash Items | — | — | 0.01 | 0.068 | -1.17 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.062 | 0.06 | 0.015 | 0.005 | -1.73 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.032 | -0.031 | -0.205 | -0.7 | -2.47 |
| Other Investing Cash Flow Items | 0 | 0 | -1.5 | -1.23 | — |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | -1.5 | -1.23 | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.032 | 0.031 | 1.8 | 1.87 | 3.87 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0 | 0 | 0.094 | -0.06 | 1.4 |